Free Trial

Autolus Therapeutics (AUTL) SEC Filings & 10K Form

$3.82
-0.05 (-1.29%)
(As of 01:47 PM ET)

Recent Autolus Therapeutics SEC Filings

DateFilerForm TypeView
05/17/2024
7:27 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
8:33 AM
Autolus Therapeutics (Filer)
Form NT 10-Q
05/13/2024
6:23 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
6:06 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:10 PM
Autolus Therapeutics (Subject)
Kellnerova Renata (Filed by)
Form SC 13D/A
03/21/2024
3:21 PM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
3:21 PM
Autolus Therapeutics (Filer)
Form 8-K/A
03/14/2024
11:32 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/23/2024
4:28 PM
Autolus Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
02/14/2024
1:41 PM
ARMISTICE CAPITAL, LLC (Filed by)
Autolus Therapeutics (Subject)
Form SC 13G/A
02/14/2024
7:37 AM
Autolus Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
02/13/2024
5:41 PM
Autolus Therapeutics (Subject)
Syncona Portfolio Ltd (Filed by)
Form SC 13G/A
02/09/2024
4:15 PM
Autolus Therapeutics (Filer)
Form 424B5
02/08/2024
3:17 PM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
9:00 PM
Autolus Therapeutics (Filer)
Form S-3ASR
02/08/2024
5:06 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:10 PM
Autolus Therapeutics (Subject)
Tetragon Financial Management LP (Filed by)
Form SC 13G/A
01/26/2024
12:02 PM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2024
2:12 PM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
7:24 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
7:31 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/27/2023
6:07 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
8:18 AM
Autolus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:26 PM
Autolus Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/03/2023
3:32 PM
Autolus Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/21/2023
3:07 PM
Autolus Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/10/2023
4:00 PM
Autolus Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
Form SC 13G
07/06/2023
3:29 PM
Autolus Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2023
7:18 AM
Autolus Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/06/2023
7:11 AM
Autolus Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AUTL) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners